Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chad Williamson, Terry Ann Glauser, B. Stephen Burton, Doron Schneider, Anne Marie Dubois & Daxa Patel. (2014) Health Care Provider Management of Patients With Type 2 Diabetes Mellitus: Analysis of Trends in Attitudes and Practices. Postgraduate Medicine 126:3, pages 145-160.
Read now
Read now
Mark Peyrot & Richard R Rubin. (2011) Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients’ cognitive framework. Patient Preference and Adherence 5, pages 255-265.
Read now
Read now
R.R. Rubin & M. Peyrot. (2011) Factors associated with physician perceptions of and willingness to recommend inhaled insulin. Current Medical Research and Opinion 27:2, pages 285-294.
Read now
Read now
Edward S. Kimball & Mark Aagren. (2011) Coverage of insulin delivery devices and basal insulin analogs by US managed care organizations. Journal of Medical Economics 14:6, pages 720-728.
Read now
Read now
Articles from other publishers (10)
Molly L. Tanenbaum, Rebecca N. Adams, Monica S. Lanning, Sarah J. Hanes, Bianca I. Agustin, Diana Naranjo & Korey K. Hood. (2018) Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption. Journal of Diabetes Science and Technology 12:6, pages 1108-1115.
Crossref
Crossref
Wenhui Wei, Erin Buysman, Michael Grabner, Lin Xie, Lee Brekke, Xuehua Ke, James W. Chu & Philip A. Levin. (2017) A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies. Diabetes, Obesity and Metabolism 19:3, pages 375-386.
Crossref
Crossref
M. Peyrot, Y. Xu & R. R. Rubin. (2014) Development and validation of the Diabetes Medication System Rating Questionnaire‐Short Form. Diabetic Medicine 31:10, pages 1237-1244.
Crossref
Crossref
Sarah Thayer, Wenhui Wei, Erin Buysman, Lee Brekke, William Crown, Michael Grabner, Swetha Raparla, Ralph Quimbo, Mark J. Cziraky, Wenli Hu & Robert Cuddihy. (2013) The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy. Advances in Therapy 30:12, pages 1128-1140.
Crossref
Crossref
Stuart A. Ross. (2013) Breaking Down Patient and Physician Barriers to Optimize Glycemic Control in Type 2 Diabetes. The American Journal of Medicine 126:9, pages S38-S48.
Crossref
Crossref
Estella M. DavisPamela A. ForalRyan B. DullApril N. Smith. (2013) Review of Insulin Therapy and Pen Use in Hospitalized Patients. Hospital Pharmacy 48:5, pages 396-405.
Crossref
Crossref
Melissa L Magwire. (2011) Addressing Barriers to Insulin Therapy: The Role of Insulin Pens. American Journal of Therapeutics 18:5, pages 392-402.
Crossref
Crossref
Hwee Teoh, Philip HomeLawrence A. Leiter. (2011) Should A1C Targets Be Individualized for All People With Diabetes?. Diabetes Care 34:Supplement_2, pages S191-S196.
Crossref
Crossref
Mark PeyrotRichard R. Rubin. (2011) Factors Associated with Persistence and Resumption of Insulin Pen Use for Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 13:1, pages 43-48.
Crossref
Crossref
Riccardo Perfetti. (2010) Reusable and Disposable Insulin Pens for the Treatment of Diabetes: Understanding the Global Differences in User Preference and an Evaluation of Inpatient Insulin Pen Use. Diabetes Technology & Therapeutics 12:S1, pages S-79-S-85.
Crossref
Crossref